ProtoKinetix

PKTX · OTC

$0.0004+$0.0002 (+100.00%)TodayMarket closed · Oct 20, 9:38 AM ET

No price history for this range.

About PKTX

Protokinetix, Inc. is a research and development stage biotechnology company engaged in the scientific medical research of anti-aging glycoproteins. The company is headquartered in Dalton, Ohio. The company went IPO on 2002-01-07. Company is focused on scientific medical research of Anti-Freeze Glycoproteins (AFGPs) or anti-aging glycoproteins. The firm's anti-aging glycopeptide is for ophthalmology, dermatology, transplant support and biomanufacturing. The commercial applications for AAGPs include various health care solutions. The firm has not developed a commercially viable product and has not generated any revenue.

Employees: 0
Headquarters: Dalton, Ohio
Listed: Jan 7, 2002
Sector: Health Care
Industry: Biotechnology
Website: protokinetix.com

Leadership

ProtoKinetix executives
Name	Title	Since	Age
Michael Guzzetta	—	2017	67
Edward McDonough	—	—	73

Similar companies

Companies in the same industry as ProtoKinetix

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.